Prevention of local thromboembolic complications during continuous infusion of coagulation factor concentrates: parallel infusion of saline versus heparin and parallel infusion of saline?

Prevention of local thromboembolic complications during continuous infusion of coagulation factor concentrates: parallel infusion of saline versus heparin and parallel infusion of saline? - Continuous infusion of factor concentrate: with or without heparin?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON36776

Enrollment

Registered

2009-10-02

Start date

2011-08-16

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bleeding disorder Haemophilia

Interventions

Two interventions will be compared. In the first group the intervention consists of adding heparin, next to a parallel infusion of saline, to the clotting factor concentrates during continous infusi

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients with haemophilia A - Planned for elective operation - Getting a continuous infusion of coagulation factor concentrates (FVIII) - 18 years and older

Exclusion criteria

Exclusion criteria: Under 18 years The use of FVIIa (used by patients with inhibitors)

Design outcomes

Primary

Measure	Time frame
Lifespan of the intravenous catheters in both groups.	—

Secondary

Measure	Time frame
V.I.P. score, a standardised score for thrombophlebitis.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)